Niva Bupa Health Insurance reported a Profit After Tax (PAT) of ₹137.8 crore for Q1 FY27. The company saw strong 47.1% growth in its retail health segment, outpacing industry trends.
Niva Bupa Health Insurance Q1 FY27 Results
Niva Bupa Health Insurance Company Limited reported a Profit After Tax (PAT) of ₹137.8 crore for the first quarter of FY27.
Reader Takeaway: Strong retail growth with improved operational efficiency faces challenges in the group segment.
What just happened
The company announced its Q1 FY27 financial results, showing a PAT of ₹137.8 crore. The retail health business demonstrated robust growth of 47.1% on a reported basis and 35.5% on a like-to-like basis.
Why this matters
Niva Bupa's performance indicates its ability to capture market share in the growing retail health insurance segment. Improved operational ratios like the Combined Insurance Service Ratio (CISR) and Expense of Management (EoM) ratio suggest better efficiency.
The backstory
Niva Bupa Health Insurance Company Limited is a significant player in the Indian health insurance market. The company focuses on both retail and group health insurance segments.
What changes now
The board has approved forming a debt-raising committee to raise up to ₹500 crore. This capital is earmarked for growth initiatives and refinancing existing Non-Convertible Debentures (NCDs).
Risks to watch
The B2B group segment is experiencing flat growth due to a challenging pricing environment. The company is prioritizing underwriting discipline over aggressive expansion in this segment.
Peer comparison
(No specific peer comparison data available in the filing).
Context metrics (time-bound)
- Combined Insurance Service Ratio (CISR) improved to 100.2% in Q1 FY27 from 103.2% in Q1 FY26.
- Expense of Management (EoM) Ratio decreased to 35.2% in Q1 FY27 from 38.0% in Q1 FY26.
- Claims settlement rate stood at 95.6% for Q1 FY27.
- Asset Under Management (AUM) is ₹9,963 crore (book value).
- Annualized investment yield was 7.2%.
- Solvency ratio was 2.25 (regulatory minimum 1.50).
What to track next
Investors will be watching the company's strategy for utilizing the authorized fundraising and its ability to sustain retail growth while managing group segment pressures.
